Literature DB >> 22453690

Current Use of Pelvic Organ Prolapse Quantification by AUGS and ICS Members.

Thythy Pham1, Alyssa Burgart, Kimberly Kenton, Elizabeth R Mueller, Linda Brubaker.   

Abstract

OBJECTIVE: : To determine the current use of the pelvic organ prolapse quantification (POP-Q) by members of the American Urogynecologic Society (AUGS) and the International Continence Society (ICS).
METHODS: : Surgically active members of AUGS and ICS completed a Web-based questionnaire about their use of the POP-Q and included queries regarding respondent's clinical training, surgical experience, and practice setting. Users of POP-Q described their POP-Q use including patient's position, tools used to measure or assist with exposure, use of strain, and bladder volume. Strengths and weaknesses of the POP-Q system were also assessed.
RESULTS: : The 308 respondents had a median of 8 years (range, 0-35 years) of independent performance of POP surgery. Most were from the United States (70%), in a shared practice (64%), with at least 2 years of fellowship training (61%), and had trainees participating in patient care (81%). Of the respondents, 76% reported using the POP-Q; however, the technique of POP-Q varied. Of the 24% not using the POP-Q, two-thirds reported past POP-Q use. For these individuals, prolapse description was done using Baden-Walker (57%), descriptive words (38%), or other grades (7%). More than 50% of nonusers reported that the POP-Q is "too time-consuming" or that their "colleagues do not use it."
CONCLUSIONS: : Although most surveyed members of AUGS and ICS are using the POP-Q, we detected variability in the day-to-day practice of POP-Q use. To further advance the communication benefits of the POP-Q, a revision that provides evidence-based guidance may be a worthwhile refinement.

Entities:  

Year:  2011        PMID: 22453690     DOI: 10.1097/SPV.0b013e318207c904

Source DB:  PubMed          Journal:  Female Pelvic Med Reconstr Surg        ISSN: 2151-8378            Impact factor:   2.091


  8 in total

1.  What is abnormal uterine descent on translabial ultrasound?

Authors:  Ka Lai Shek; Hans Peter Dietz
Journal:  Int Urogynecol J       Date:  2015-07-15       Impact factor: 2.894

2.  A randomised controlled trial of abdominal versus laparoscopic sacrocolpopexy for the treatment of post-hysterectomy vaginal vault prolapse: LAS study. Reply to comment.

Authors:  R M Freeman; K Pantazis; A Thomson; J Frappell; L Bombieri; P Moran; M Slack; P Scott; M Waterfield
Journal:  Int Urogynecol J       Date:  2014-03       Impact factor: 2.894

3.  Total vaginal length: Does it matter for assessing uterine prolapse?

Authors:  Myriam Girgis; Ka Lai Shek; Hans Peter Dietz
Journal:  Int Urogynecol J       Date:  2018-10-24       Impact factor: 2.894

4.  Positional pelvic organ prolapse (POP) evaluation using open, weight-bearing magnetic resonance imaging (MRI).

Authors:  Boris Friedman; Lynn Stothers; Darren Lazare; Andrew Macnab
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

5.  Current use of the pelvic organ prolapse quantification system in clinical practice among Korean obstetrician-gynecologists.

Authors:  Soo Rim Kim; Dong Hoon Suh; Myung Jae Jeon
Journal:  BMC Womens Health       Date:  2021-05-18       Impact factor: 2.809

6.  Underestimation of pelvic organ prolapse in the supine straining position, based on magnetic resonance imaging findings.

Authors:  Anique T M Grob; Judith Olde Heuvel; Jurgen J Futterer; Diana Massop; Angelique L Veenstra van Nieuwenhoven; Frank F J Simonis; Carl H van der Vaart
Journal:  Int Urogynecol J       Date:  2019-01-17       Impact factor: 2.894

7.  Pelvic inclination correction system for magnetic resonance imaging analysis of pelvic organ prolapse in upright position.

Authors:  Lisan M Morsinkhof; Martine K Schulten; John O L DeLancey; Frank F J Simonis; Anique T M Grob
Journal:  Int Urogynecol J       Date:  2022-07-30       Impact factor: 1.932

8.  Demand and capacity to integrate pelvic organ prolapse and genital fistula services in low-resource settings.

Authors:  Vandana Tripathi; Sohier Elneil; Lauri Romanzi
Journal:  Int Urogynecol J       Date:  2018-02-06       Impact factor: 2.894

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.